Clinical trials
Completed Phase 1 Drug-Related Side Effects and Adverse Reactions trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2004 | 2 |
| 2006 | 1 |
| 2007 | 1 |
| 2010 | 1 |
| 2013 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2022 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 1 |
| Barbara Ann Karmanos Cancer Institute | 1 |
| GlaxoSmithKline | 1 |
| H. Lundbeck A/S | 1 |
| Indiana University | 1 |
| Kwang Dong Pharmaceutical co., ltd. | 1 |
| Linda Van Eldik | 1 |
| NYU Langone Health | 1 |
| National Cancer Institute (NCI) | 1 |
| New Approaches to Neuroblastoma Therapy Consortium | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Drug-Related Side Effects and Adverse Reactions | 16 |
| Multiple Myeloma | 3 |
| Burkitt Lymphoma | 2 |
| Hodgkin Disease | 2 |
| Leukemia | 2 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 |
| Leukemia, Myeloid, Acute | 2 |
| Lymphoma | 2 |
| Lymphoma, B-Cell, Marginal Zone | 2 |
| Lymphoma, Follicular | 2 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.